RNA, U6 small nuclear 977, pseudogene (RNU6-977P)

RNA, U6 small nuclear 977, pseudogene (RNU6-977P) is a human genomic sequence classified as a pseudogene derived from the U6 small nuclear RNA (snRNA) gene family[1][2][5]. U6 snRNA itself is a highly conserved, essential non-coding RNA that forms part of the spliceosome, the molecular machinery responsible for excising introns from pre-mRNA during splicing[3][5]. However, RNU6-977P does not encode a functional RNA, lacks intronic sequence, and is best considered a processed pseudogene—a product of retrotransposition events that copied the parental U6 snRNA sequence into new genomic locations without preserving function[2]. Like most pseudogenes, RNU6-977P is not known to produce any functional molecule, has no recognized therapeutic relevance, and is not considered a druggable or relevant biological target. There is no current evidence for its involvement in disease, interaction with drugs, or use as a biomarker. Its only biological significance is as a remnant of genome evolution; in some cases, other pseudogenes may regulate their parental genes or act as competitive endogenous RNAs (ceRNAs)[4], but such a function is not described for RNU6-977P. Key points: - RNU6-977P is not a therapeutic target, enzyme, receptor, or relevant molecular entity for drug development. - It is a noncoding, unprocessed or processed pseudogene, descended from the U6 snRNA, which is itself vital for pre-mRNA splicing, but the pseudogene does not retain this function[2][3][5]. - There is nothing to suggest it is clinically actionable or currently relevant to disease. Note: - This entry is marked as incorrect for target analysis because pseudogenes like RNU6-977P lack protein products, function, or therapeutic relevance, and are not considered targets unless new functional evidence emerges.

Other names

RNU6-977PU6 snRNA pseudogene 977RNA, U6 Small Nuclear 977, Pseudogene